Standard BioTools Total Long Term Liabilities 2010-2024 | LAB
Standard BioTools total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
| Standard BioTools Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $51 |
| 2022 | $117 |
| 2021 | $131 |
| 2020 | $131 |
| 2019 | $78 |
| 2018 | $194 |
| 2017 | $223 |
| 2016 | $224 |
| 2015 | $225 |
| 2014 | $228 |
| 2013 | $3 |
| 2012 | $1 |
| 2011 | $2 |
| 2010 | $195 |
| 2009 | $15 |
| Standard BioTools Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $72 |
| 2024-06-30 | $75 |
| 2024-03-31 | $79 |
| 2023-12-31 | $51 |
| 2023-09-30 | $108 |
| 2023-06-30 | $111 |
| 2023-03-31 | $114 |
| 2022-12-31 | $117 |
| 2022-09-30 | $120 |
| 2022-06-30 | $125 |
| 2022-03-31 | $203 |
| 2021-12-31 | $131 |
| 2021-09-30 | $136 |
| 2021-06-30 | $127 |
| 2021-03-31 | $129 |
| 2020-12-31 | $131 |
| 2020-09-30 | $128 |
| 2020-06-30 | $111 |
| 2020-03-31 | $113 |
| 2019-12-31 | $78 |
| 2019-09-30 | $73 |
| 2019-06-30 | $74 |
| 2019-03-31 | $75 |
| 2018-12-31 | $194 |
| 2018-09-30 | $191 |
| 2018-06-30 | $188 |
| 2018-03-31 | $187 |
| 2017-12-31 | $223 |
| 2017-09-30 | $221 |
| 2017-06-30 | $220 |
| 2017-03-31 | $223 |
| 2016-12-31 | $224 |
| 2016-09-30 | $225 |
| 2016-06-30 | $225 |
| 2016-03-31 | $225 |
| 2015-12-31 | $225 |
| 2015-09-30 | $227 |
| 2015-06-30 | $227 |
| 2015-03-31 | $228 |
| 2014-12-31 | $228 |
| 2014-09-30 | $229 |
| 2014-06-30 | $229 |
| 2014-03-31 | $232 |
| 2013-12-31 | $3 |
| 2013-09-30 | $2 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $2 |
| 2011-09-30 | $4 |
| 2011-06-30 | $6 |
| 2011-03-31 | $7 |
| 2010-12-31 | $195 |
| 2010-09-30 | $12 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.495B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |